FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $826 | -14.9% | 110 | 0.0% | 0.00% | – |
| Q2 2023 | $971 | -96.2% | 110 | -96.4% | 0.00% | – |
| Q1 2023 | $25,459 | -31.2% | 3,060 | -21.4% | 0.00% | – |
| Q4 2022 | $37,000 | -58.9% | 3,892 | -65.0% | 0.00% | – |
| Q3 2022 | $90,000 | +42.9% | 11,110 | -1.0% | 0.00% | – |
| Q2 2022 | $63,000 | 0.0% | 11,220 | 0.0% | 0.00% | – |
| Q1 2022 | $63,000 | +31.2% | 11,220 | +2.3% | 0.00% | – |
| Q4 2021 | $48,000 | -59.0% | 10,970 | -11.3% | 0.00% | – |
| Q3 2021 | $117,000 | +30.0% | 12,370 | 0.0% | 0.00% | – |
| Q2 2021 | $90,000 | +429.4% | 12,370 | +359.9% | 0.00% | – |
| Q1 2021 | $17,000 | – | 2,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |